✦ LIBER ✦

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

✍ Scribed by Mark R. Gilbert; John Kuhn; Kathleen R. Lamborn; Frank Lieberman; Patrick Y. Wen; Minesh Mehta; Timothy Cloughesy; Andrew B. Lassman; Lisa M. DeAngelis; Susan Chang; Michael Prados

Book ID: 106481952
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 202 KB
Volume: 106
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-011-0650-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

A phase II clinical trial of diaziquone

A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus

✍ Robert E. Slayton; John A. Blessing; Katherine Look; Barrie Anderson 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 115 KB

Phase II trial of two different irinotec

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

✍ Marta Santisteban; Jan C. Buckner; Joel M. Reid; Wenting Wu; Bernd W. Scheithaue 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 235 KB

Thalidomide in the treatment of patients

Thalidomide in the treatment of patients with hepatocellular carcinoma : A Phase II trial

✍ Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Ajay K. Nooka; Isaac I. Schn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that pote

A phase II clinical trial of diaziquone

A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix

✍ Robert E. Slayton; John A. Blessing; Mark Rettenmaier; Harrison Ball 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 251 KB

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

✍ Francesco Boccardo; Maurizio Pace; Domenico Guarneri; Luciano Canobbio; Antonio 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 3 views